(openPR) (Amherst, NH) - Infusion is one of the most common therapeutic procedures that patients in a hospital setting are likely to receive. Yet the lack of standardization among the various components, elements and steps that a caregiver must navigate to successfully execute a drug infusion have – according to several recent studies – contributed to medication errors and risks to patient safety.
The current generation of what can be referred to as advanced infusion pumps – ‘smart’ pumps – are attempting to address the risks associated with infusion by incorporating electronic and programmable features that either simplify the medication process or alert the caregiver to potential dangers or inconsistencies. New capabilities such as onboard drug libraries, dose error reduction software and wireless connectivity that allow the pump to interface with patient EMRs and patient monitors are pushing infusion toward a new era where the complexities inherent in the drug infusion process can be automated and the associated risks reduced.
Greystone’s analysis of the commercial market for smart infusion pumps is summarized in a new and comprehensive report. Smart Infusion Pumps: Products, Markets, Players and Prospects includes analysis of the global market for smart pumps, assessments of evolving smart pump products and technology, an examination of the dynamics of patient care that will affect market development, profiles of market sector companies, and market data and forecasts.
More information is available at www.greystoneassociates.org .
Source: Greystone Research Associates









